Cargando…
Combining secukinumab and apremilast to successfully treat refractory psoriatic skin and joint disease: A novel approach
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medical Research and Education Association
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6459333/ https://www.ncbi.nlm.nih.gov/pubmed/30071939 http://dx.doi.org/10.5152/eurjrheum.2018.17188 |
_version_ | 1783410163826294784 |
---|---|
author | Nisar, Muhammad K. |
author_facet | Nisar, Muhammad K. |
author_sort | Nisar, Muhammad K. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6459333 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Medical Research and Education Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-64593332019-04-19 Combining secukinumab and apremilast to successfully treat refractory psoriatic skin and joint disease: A novel approach Nisar, Muhammad K. Eur J Rheumatol Letter to the Editor Medical Research and Education Association 2019-01 2018-04-19 /pmc/articles/PMC6459333/ /pubmed/30071939 http://dx.doi.org/10.5152/eurjrheum.2018.17188 Text en © Copyright by 2019 Medical Research and Education Association http://creativecommons.org/licenses/by-nc/4.0/ Content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
spellingShingle | Letter to the Editor Nisar, Muhammad K. Combining secukinumab and apremilast to successfully treat refractory psoriatic skin and joint disease: A novel approach |
title | Combining secukinumab and apremilast to successfully treat refractory psoriatic skin and joint disease: A novel approach |
title_full | Combining secukinumab and apremilast to successfully treat refractory psoriatic skin and joint disease: A novel approach |
title_fullStr | Combining secukinumab and apremilast to successfully treat refractory psoriatic skin and joint disease: A novel approach |
title_full_unstemmed | Combining secukinumab and apremilast to successfully treat refractory psoriatic skin and joint disease: A novel approach |
title_short | Combining secukinumab and apremilast to successfully treat refractory psoriatic skin and joint disease: A novel approach |
title_sort | combining secukinumab and apremilast to successfully treat refractory psoriatic skin and joint disease: a novel approach |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6459333/ https://www.ncbi.nlm.nih.gov/pubmed/30071939 http://dx.doi.org/10.5152/eurjrheum.2018.17188 |
work_keys_str_mv | AT nisarmuhammadk combiningsecukinumabandapremilasttosuccessfullytreatrefractorypsoriaticskinandjointdiseaseanovelapproach |